文献速递角膜与眼表疾病眼整形与眼眶

眼部玫瑰痤疮中p38与Erk丝裂原活化蛋白激酶信号的激活

Activation of p38 and Erk Mitogen-Activated Protein Kinases Signaling in Ocular Rosacea.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

这项观察性比较病例系列研究分析了眼睑皮肤活检中细胞内信号活性,发现眼部玫瑰痤疮患者磷酸化(活性)p38和Erk激酶水平升高,且磷酸化蛋白主要定位于受累眼睑表皮。作者认为该发现为眼部玫瑰痤疮提供了新的潜在治疗靶点,但需进一步检测以确定p38和Erk激活是否具有因果作用。

要点

  • 眼部玫瑰痤疮患者眼睑皮肤中磷酸化p38和Erk激酶水平升高。
  • 磷酸化蛋白主要定位于受累眼睑的表皮。
  • 作者认为局部通路抑制可能是有效治疗,但需进一步检测因果作用。

核心结论

  • 眼部玫瑰痤疮患者眼睑皮肤中磷酸化(活性)p38和Erk激酶水平升高,该发现为眼部玫瑰痤疮及可能其他形式玫瑰痤疮提供了新的潜在治疗靶点。
  • 需进一步检测以确定p38和Erk激活在眼部玫瑰痤疮中是否具有因果作用。
  • 受累皮肤中角质形成细胞的选择性激活提示局部通路抑制可能是有效治疗,最终预防眼部玫瑰痤疮导致的眼表损害。

研究设计与样本

  • 观察性比较病例系列,包括2013年至2014年期间在同一执业机构接受下睑外翻手术的21例患者(18例玫瑰痤疮患者,13例对照患者),以及来自Albany Medical Center随机选取的24例石蜡包埋存档样本(12例玫瑰痤疮患者,12例对照患者)。
  • 对择期下睑外翻手术获得的皮肤活检组织,采用Proteome Profiler人磷酸化激酶阵列、Western blot和/或免疫组织化学进行分析。

主要发现

  • 源自眼部玫瑰痤疮患者的样本显示磷酸化(活性)p38和Erk激酶水平升高。
  • 磷酸化蛋白主要定位于受累眼睑的表皮。

临床怎么用

  • 作者认为该发现为眼部玫瑰痤疮提供了新的潜在治疗靶点,并提示局部通路抑制可能是有效治疗,但需进一步检测以确定p38和Erk激活是否具有因果作用。

局限性

  • 需进一步检测以确定p38和Erk激活在眼部玫瑰痤疮中是否具有因果作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Rosacea-related cutaneous inflammation is a common cause of ocular surface disease. Currently, there are no specific pharmacologic therapies to treat ocular rosacea. Here, we aimed at determining the differences in intracellular signaling activity in eyelid skin from patients with and without ocular rosacea. METHODS: This was an observational, comparative case series including 21 patients undergoing lower lid ectropion surgery at one practice during 2013 and 2014 (18 patients with rosacea, 13 control patients), and 24 paraffin-embedded archival samples from Albany Medical Center, selected randomly (12 patients with rosacea, 12 control patients). Cutaneous biopsies resulting from elective lower lid ectropion surgery were analyzed by Proteome Profiler Human Phospho-Kinase Array, Western blot, and/or immunohistochemistry. RESULTS: Samples derived from ocular rosacea patients showed increased levels of phosphorylated (active) p38 and Erk kinases. Phosphoproteins were mainly localized to the epidermis of affected eyelids. CONCLUSIONS: This finding provides a novel potential therapeutic target for treatment of ocular rosacea and possibly other forms of rosacea. Further testing is required to determine if p38 and Erk activation have a causal role in ocular rosacea. The selective activation of keratinocytes in the affected skin suggests that topical pathway inhibition may be an effective treatment that will ultimately prevent ocular surface damage due to ocular rosacea.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Wladis EJ, Swamy S, Herrmann A, et al. Activation of p38 and Erk Mitogen-Activated Protein Kinases Signaling in Ocular Rosacea. Invest Ophthalmol Vis Sci. 2017. PMID: 28170535. doi:10.1167/iovs.16-20275

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。